publication date: Mar. 30, 2018

In Brief

Society of Surgical Oncology gives service award to Wolmark and Fisher

The Society of Surgical Oncology has awarded the Charles Balch Distinguished Service Award to Norman Wolmark and Bernard Fisher for their work with the National Surgical Adjuvant Breast and Bowel Project.

Wolmark, is chairman of NSABP Foundation, a not-for-profit academic research organization with a history of conducting groundbreaking research studies in breast and colorectal cancer. He also serves as chair and principal investigator of NCI-funded NRG Oncology. He is professor and chairman of human oncology at Drexel University School of Medicine.

Fisher’s research has transformed current surgery, radiation therapy, and systemic adjuvant chemotherapy and hormonal therapy modalities for the treatment of breast and other cancers. As chairman of the NSABP, Fisher designed and conducted large-scale multi-institutional randomized clinical trials to test his hypothesis, based upon his laboratory research, that breast cancer is likely to be systemic at diagnosis.

As a major consequence of two of his landmark trials, the prevailing paradigm governing the treatment of breast and other cancers for almost a century was supplanted by a new paradigm, and radical surgery began to be replaced by less-mutilating operations.

Fisher and colleagues were also the first to demonstrate that, when used as a preventive agent, tamoxifen significantly reduces breast cancer in women at high risk for the disease. Fisher is credited with establishing the scientific approach to the understanding and treatment of breast cancer that has led to improvement in both survival rate and quality of life for women with the disease.

 

NCCN honors contributors to the Improvement of global cancer care

The National Comprehensive Cancer Network announced the recipients of … Continue reading Society of Surgical Oncology gives service award to Wolmark and Fisher

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2019 The Cancer Letter Inc.